Saturday, December 13, 2025 | 09:56 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Dabur India PAT up 24% to Rs 494 cr in Q3, operating revenue rises 16%

OTC drugs, health supplements and immunity boosting products grow in healthy double digits

Dabur, Dabur India
premium

Over-the-counter medicines, health supplements and immunity boosting products from the portfolio grew by healthy double digits

Arnab Dutta New Delhi
Fast moving consumer goods (FMCG) major Dabur India reported a 23.7 percent year-on-year jump in net profit for the October-December quarter. The firm's profit after tax (PAT) rose to Rs 494 crore from Rs 399 crore during the corresponding quarter previous year.

Dabur's operating revenue recorded a healthy 16 percent yoy growth to Rs 2729 crore - up from Rs 2353 crore - backed by a strong volume uptake. During the quarter, it reported a 18 percent surge in its volume offtake.

Over-the-counter medicines, health supplements and immunity boosting products from the portfolio grew by healthy double digits, apart from